Procurement Summary
Country: USA
Summary: Optimizing Treatment Strategies For Adult Attention-Deficit Hyperactivity Disorder (Adhd) (R01 Clinical Trial Required)
Deadline: 25 Nov 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 126546612
Document Ref. No.: RFA-MH-26-195
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
The Objective Of This Nofo Is To Provide Evidence For The Optimal Treatment Of Adhd In Adults, Given Its Relatively Recent Acceptance As A Formal Diagnostic Category. While Stimulant Drugs Offer The Advantages Of Rapid Onset Of Action And History Of Efficacy, The Risk Of Adverse Effects, Dependence, Misuse, And Diversion, Along With Recent Medication Shortages, Underscore The Importance Of Studying Evidence-Based Complementary And Alternative Approaches When Indicated. Clinical Trials Testing Non-Stimulant Medications, Psychosocial Interventions, And Device-Based Approaches, Sequentially Or In Combination, To Augment Or Replace Stimulants In Situations Where Stimulant Monotherapy Is Insufficiently Effective, Difficult To Tolerate, Or Undesirable, In The Acute And Post-Acute Treatment Of Adhd In Adults, Or In Preventing The Transition Of Adhd Symptoms From Adolescence To Adulthood, Will Be Supported By This Nofo.
Opportunity Category : Discretionary
Opportunity Category Explanation :
Funding Instrument Type : Grant
Category of Funding Activity : Health
CFDA_Number :
Posted Date : Sep 17, 2025
Last Updated Date : Sep 17, 2025
Documents
Tender Notice